Page last updated: 2024-11-01
nomifensine and HIV Infections
nomifensine has been researched along with HIV Infections in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
Davis, SE | 3 |
Ferris, MJ | 3 |
Ananthan, S | 3 |
Augelli-Szafran, CE | 3 |
Zhu, J | 3 |
Other Studies
1 other study available for nomifensine and HIV Infections
Article | Year |
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2
Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice; | 2023 |
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2
Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice; | 2023 |
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2
Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice; | 2023 |
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.The Journal of pharmacology and experimental therapeutics, 2023, Volume: 384, Issue:2
Topics: Animals; Dopamine; Dopamine Plasma Membrane Transport Proteins; HIV Infections; HIV-1; Humans; Mice; | 2023 |